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Abstract
AIM: To assess whether non invasive blood flow mea-
surement by arterial spin labeling in several brain re-
gions detects minimal hepatic encephalopathy. 
METHODS: Blood flow (BF) was analyzed by arte-
rial spin labeling (ASL) in different brain areas of 14 
controls, 24 cirrhotic patients without and 16 cirrhotic 
patients with minimal hepatic encephalopathy (MHE). 
Images were collected using a 3 Tesla MR scanner 
(Achieva 3T-TX, Philips, Netherlands). Pulsed ASL was 
performed. Patients showing MHE were detected us-
ing the battery Psychometric Hepatic Encephalopathy 
Score (PHES) consisting of five tests. Different cognitive 
and motor functions were also assessed: alterations 
in selective attention were evaluated using the Stroop 
test. Patients and controls also performed visuo-motor 
and bimanual coordination tests. Several biochemical 
parameters were measured: serum pro-inflammatory 
interleukins (IL-6 and IL-18), 3-nitrotyrosine, cGMP and 
nitrates+nitrites in plasma, and blood ammonia. Bivari-
ate correlations were evaluated.
RESULTS: In patients with MHE, BF was increased 
in cerebellar hemisphere (P  = 0.03) and vermis (P  = 
0.012) and reduced in occipital lobe (P  = 0.017). BF in 
cerebellar hemisphere was also increased in patients 
without MHE (P  = 0.02). Bimanual coordination was 
impaired in patients without MHE (P  = 0.05) and much 
more in patients with MHE (P  < 0.0001). Visuo-motor 
coordination was impaired only in patients with MHE (P  
< 0.0001). Attention was slightly affected in patients 
without MHE and more strongly in patients with MHE (P  
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may include selective alterations in blood flow (BF)[6].
Invasive positron emission tomography (PET) and 
single photon emission computed tomography (SPECT) 
techniques have shown altered cerebral blood flow (CBF) 
patterns in cirrhotic patients, but there is a large variabil-
ity between the results published[6-9]. Some studies show 
redistribution of  the BF from cortex to thalamus and 
cerebellum[6]. However, Iwasa et al[7,8] reported reduced 
BF both in cortex, cerebellum and cingulate gyrus of  
cirrhotic patients. These differences may reflect different 
grades in the progression of  the disease.
The possible contribution of  alterations in BF in 
specific brain areas to neurological alterations in patients 
with MHE remains unclear. Ahl et al[6] found that there 
was no association between changes in CBF and neuro-
psychiatric status. However, Catafau et al[9] reported a cor-
relation between altered BF in basal ganglia and reduced 
performance in the “Luria Motor Alternances” and 
“Purdue Pegboard” tests. Iwasa et al[7,8] did not find cor-
relations between reduced BF in frontal lobe and neuro-
psychological alterations, but later reported a correlation 
between reduced BF in cingulate gyrus and performance 
in psychometric tests. This suggests that BF alterations 
in some specific regions could be involved in the mecha-
nisms leading to certain cognitive and motor alterations.
The above studies were performed using invasive 
techniques. It would be useful to have non-invasive pro-
cedures to analyze regional CBF and evaluate if  BF in 
some region is useful to detect MHE and/or specific 
neurological alterations. This would allow early treatment 
and follow-up of  the eficiency of  therapeutic treatments.
Arterial spin labeling (ASL) is a completely non-
invasive magnetic resonance technique that quantitatively 
measures cerebral perfusion by magnetically labeling pro-
tons in arterial blood water. The labeled protons travel 
through the vascular tree and exchange water with non 
labeled cerebral tissue. The perfusion cerebral image is 
obtained by substracting the images with the labeled and 
unlabeled protons[10].
An important modulator of  CBF is the nitric oxide 
(NO)-cGMP system[11], which also modulates some 
forms of  learning and memory. Altered function of  the 
glutamate-NO-cGMP pathway in brain is responsible for 
some types of  cognitive impairment in animal models of  
MHE. Normalizing this system by pharmacological treat-
ments restores learning ability[12-14]. It is therefore likely 
that altered NO-cGMP system could contribute to alter 
BF in some brain areas which could contribute to cogni-
tive impairment. Detection of  altered CBF by magnetic 
resonance could serve as an indicator of  mild cognitive 
impairment in MHE. Identifying some parameter in 
blood reflecting altered CBF in patients with liver disease 
would be also useful. 
The aims of  this work were to: (1) analyze by ASL 
the BF in brain areas of  patients with liver cirrhosis; (2) 
assess whether patients with or without MHE show simi-
lar or different alterations; (3) assess if  BF in some brain 
area may be a good indicator of  MHE or of  specific neu-
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< 0.0001). BF in cerebellar hemisphere and vermis cor-
related with performance in most tests of PHES [(num-
ber connection tests A (NCT-A), B (NCT-B)and line trac-
ing test] and in the congruent task of Stroop test. BF 
in frontal lobe correlated with NCT-A. Performance in 
bimanual and visuomotor coordination tests correlated 
only with BF in cerebellar hemisphere. BF in occipital 
lobe correlates with performance in the PHES battery 
and with CFF. BF in cerebellar hemisphere correlates 
with plasma cGMP and nitric oxide (NO) metabolites. 
BF in vermis cerebellar also correlates with NO metabo-
lites and with 3-nitrotyrosine. IL-18 in plasma correlates 
with BF in thalamus and occipital lobe.
CONCLUSION: Non invasive BF determination in cer-
ebellum using ASL may detect MHE earlier than the 
PHES. Altered NO-cGMP pathway seems to be associ-
ated to altered BF in cerebellum.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: Patients with minimal hepatic encephalopathy 
(MHE) show neurological impairment in specific tasks 
to which selective regional alterations in blood flow (BF) 
could contribute. Arterial spin labeling (ASL), a non-
invasive magnetic resonance technique, quantitatively 
measures cerebral perfusion. We analyzed BF by ASL 
in different brain areas of controls and cirrhotic pa-
tients without and with MHE. We found that BF is more 
affected in cerebellum than in other areas of cirrhotic 
patients and that BF determination in cerebellum us-
ing ASL may detect MHE earlier than the Psychometric 
Hepatic Encephalopathy Score battery. Altered nitric 
oxide-cGMP pathway seems to be associated to altered 
BF in cerebellum. 
Felipo V, Urios A, Giménez-Garzó C, Cauli O, Andrés-Costa MJ, 
González O, Serra MA, Sánchez-González J, Aliaga R, Giner-
Durán R, Belloch V, Montoliu C. Non invasive blood flow mea-
surement in cerebellum detects minimal hepatic encephalopathy 
earlier than psychometric tests. World J Gastroenterol 2014; 
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org/10.3748/wjg.v20.i33.11815
INTRODUCTION
Patients with minimal hepatic encephalopathy (MHE) 
show selective alterations in specific functions and tasks 
such as visuo-spatial orientation and perception, complex 
tasks requiring attention and motor abilities[1-5]. This sug-
gests that the brain areas modulating these tasks are more 
affected than others in patients with liver disease and 
MHE. The reasons for this “region selective” sensitivity 
rological alterations; and (4) assess whether some periph-
eral parameter correlates with BF. As possible peripheral 
indicators we determined parameters of  the NO-cGMP 
system in blood. We also measured ammonia levels, pa-
rameters related with inflammation and 3-nitrotyrosine[15]. 
MATERIALS AND METHODS
Patients and controls
Forty patients with liver disease and 14 controls were en-
rolled after written informed consent. Inclusion criteria: 
patients were recruited from the outpatient clinics at Hos-
pitals Clinico Universitario and Arnau de Vilanova, in Va-
lencia and were included if  they had clinical, biochemical 
and histological evidence of  liver cirrhosis. For controls 
liver disease was discarded by clinical, analytical and sero-
logic analysis. Patients were excluded if  they had evidence 
of  overt hepatic encephalopathy (HE) by the West Haven 
criteria, decompensate diabetes, renal dysfunction, hypo-
natremia, neurological disease, cardiovascular disease or 
antibiotic use. Patients had to be abstinent from alcohol 
for six months. Patients were not on any specific therapy 
for HE. After a standard history and physical examina-
tion, blood was drawn for biochemical measurements. 
The study protocol conforms to the ethical guidelines 
of  the 1975 Declaration of  Helsinki and was approved by 
the Ethical Committee of  the Hospital. After performing 
the psychometric tests, patients were classified as without 
or with MHE (see below). The study includes therefore 
three groups: (1) controls; (2) patients without MHE; and 
(3) patients with MHE. MRI examination was performed 
one week after the psychometric tests. The composition 
of  groups, age, analytical data and aetiology of  the dis-
ease are in Table 1.
Assessment of neuropsychometric status
Diagnosis of  MHE: Patients showing MHE were 
detected using the battery Psychometric Hepatic En-
cephalopathy Score (PHES). Classification of  patients as 
“with” or “without” MHE was based only on PHES per-
formance, considered as the “gold standard”[16]. PHES 
comprises 5 psychometric tests: digit symbol test (DST) 
evaluates processing speed and working memory, number 
connection tests A (NCT-A) and B (NCT-B) mental pro-
cessing speed and attention; serial dotting test (SD) and 
line tracing test (LTT) visuo-spatial coordination. The 
scores were adjusted for age and education level using 
Spanish normality tables (www.redeh.org). Patients were 
classified as having MHE when the score was less than −
4 points[17].
Evaluation of  attention with the Stroop test: The Stroop 
task evaluates selective attention. We used a colour-word 
version of  the Stroop task[18]. Each individual performed 
sequentially the congruent, neutral and incongruent tasks, 
45 s per task. The number of  items correctly named was 
quantified and adjusted by age[19].
Visuo-motor coordination: This task was performed as 
described in reference[20].
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Table 1  Composition of the groups and clinical data (mean ± SD)
Range Control Patients without MHE Patients with MHE
Total individuals 14 24 16
Age 55 ± 9 58 ± 6 65 ± 9
Alcohol 24 16
Ascitis   2   5
Child Pugh A/B/C 21/3/0 11/3/2
MELD   8.9 ± 3.5   9.5 ± 3.4
AST (mU/mL)      1-37    20 ± 4.0    73 ± 56b 82.5 ± 58b
ALT (mU/mL)      1-41    18 ± 6.0    77 ± 24b 90.1 ± 24b
GGT (mU/mL)    10-49 26.7 ± 5.0 86.4 ± 60b  106 ± 64b
Uric acid (mg/dL) 2.5-7   4.0 ± 1.0   6.2 ± 2.0 5.73 ± 2.3
Creatinine (mg/dL)    0.5-1.3 0.92 ± 0.1   1.1 ± 0.2   1.2 ± 0.2
Cholesterol (mg/dL)    140-200 172 ± 22 175 ± 44 167 ± 55
Triglycerides (mg/dL)      40-160   95 ± 32 111 ± 64 119 ± 64
Bilirubin (mg/dL) 0.1-1   0.6 ± 0.2    1.7 ± 0.7b    2.3 ± 0.6b
Albumin (g/dL) 3.5-5   4.4 ± 0.2    3.7 ± 0.6b      2.9 ± 0.6b,c
Prothrombin time (s)    13 ± 1.3  24 ± 4b   30 ± 4b
Fibrinogen (g/L)    2-4   3.1 ± 1.0   3.3 ± 1.3   3.6 ± 1.2
Alkaline phosphatase (mU/mL)      50-250 147 ± 53  216 ± 77b    314 ± 96b,c
Erythrocytes    4.2-6.1   4.6 ± 0.4   4.3 ± 0.7   3.4 ± 0.6
Leucocytes      4.8-10.8   6.5 ± 1.3      6 ± 2.6   5.5 ± 2.0
Neutrophils (%)    55-75    55 ± 7.4    54 ± 6.2    59 ± 9.3
Lymphocytes (%)    17-45    35 ± 6.0   29 ± 10    27 ± 9.4
Monocytes (%)    2-8   6.0 ± 1.3    8.4 ± 3.0b     10 ± 2.6b
Eosinophils (%)    1-4   3.3 ± 2.0   2.4 ± 1.2   1.7 ± 1.0
Basophils (%)  0.05-0.5   0.5 ± 0.2   0.6 ± 0.3   0.6 ± 0.1 
bP < 0.01 vs control, cP < 0.05 vs without minimal hepatic encephalopathy (MHE). MELD: Model for end stage liver disease. Val-
ues that are significantly different from controls are indicated by superscripts.
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followed by receiver operating characteristic (ROC) curve 
to determine sensitivity and specificity and to identify the 
optimal threshold value. Analyses were performed using 
SPSS Version 19.0 (SPSS Inc, Chicago, United states) and 
two-sided P values < 0.05 were considered significant.
RESULTS
Sixteen (40%) of  the 40 patients showed MHE according 
to PHES performance. The composition of  groups, age, 
analytical data and aetiology of  the disease are in Table 1.
Blood flow is increased in cerebellum and reduced in 
occipital lobe in MHE
BF was increased in cerebellar hemisphere and vermis in 
patients with MHE and reduced in occipital lobe (Figure 
1). BF in cerebellar hemisphere was 22 ± 2 mL/min per 
100 g in controls, 32 ± 3 mL/min per 100 g in patients 
without MHE (P = 0.02) and increased further in patients 
with MHE (36 ± 5 mL/min per 100 g) compared to con-
trol group (P = 0.03). BF in vermis were 38 ± 5 and 51 
± 5 mL/min per 100 g in controls and cirrhotics without 
MHE respectively, and increased in patients with MHE 
(75 ± 11 mL/min per 100 g) respect to control group 
(P = 0.012) and to patients without MHE (P = 0.03). In 
occipital lobe, BF was 16.6 ± 1.2 mL/min per 100 g in 
controls and 17.4 ± 1.7 mL/min per 100 g in cirrhotics 
without MHE, and decreased in patients with MHE (11.7 
± 1.1 mL/min per 100 g) compared to controls (P = 
0.017) and to patients without MHE (P = 0.02).
MHE increases blood cGMP, 3-nitrotyrosine, IL-6 and 
IL-18
Cirrhotic patients with or without MHE show increased 
blood levels of  cGMP, NO metabolites, 3-nitrotyrosine, 
IL-6, IL-18 and ammonia (Table 2). The increase in 
cGMP (P < 0.05), 3-nitrotyrosine (P < 0.0001), IL-6 (P 
= 0.001) and IL-18 (P < 0.05) was higher in patients with 
than without MHE (Table 2).
Performance in the psychometric tests 
Controls completed the bimanual coordination test in 
1.73 ± 0.05 min. Patients without MHE needed 2.16 ± 
0.05 min (P = 0.05) and patients with MHE 2.8 ± 0.1 
min, more than controls (P < 0.0001) or patients without 
MHE (P < 0.001) (Figure 2A, Table 3). In the visuo-mo-
tor coordination test, controls completed the task in 2.15 
± 0.08 min. The score was not affected in patients with-
out MHE (2.61 ± 0.08 min). Patients with MHE needed 
more time (3.9 ± 0.3 min, P < 0.0001) (Figure 2B, Table 
3). In the congruent task of  the Stroop test of  selective 
attention, controls read 102 ± 5 words. Patients without 
MHE read 90 ± 2 words (P = 0.03) and patients with 
MHE even less words (76 ± 4) which was lower than for 
controls (P < 0.0001) and patients without MHE (P = 
0.009) (Figure 2C, Table 3). In the neutral task controls 
named 75 ± 3 colours. Patients without MHE named 67 
± 2 colours (P = 0.07) and patients with MHE 54 ± 3 co-
Bimanual coordination: This task was performed as 
described in reference[21].
Critical flicker frequency: The CFF was measured as in 
reference references[22,23].
Obtention of plasma and serum
Venous blood (5 mL) was taken in BD Vacutainer tubes 
with or without EDTA (plasma and serum, respectively) 
and centrifuged at 500 g for 10 min. The supernatant was 
collected, and stored frozen at -80 ℃. 
Biochemical determinations in blood
Nitrates + nitrites in plasma were measured as previous-
ly[24]. Serum IL-6 and IL-18 were determined using ELI-
SA kits (Pierce Biotechnology, United States) and Bender 
MedSystems GmbH (Vienna, Austria), respectively. 
Plasma cGMP was determined using the BIOTRAK™ 
cGMP enzyme immunoassay kit (GE Healthcare, United 
Kingdom). Ammonia was determined with the Ammonia 
Test Kit Ⅱ (Arkay, Inc., Kyoto, Japan). 3-nitrotyrosine in 
serum was determined by HPLC as in reference[15].
Blood flow determination by arterial spin labelling
Images were collected using a 3 Tesla MR scanner 
(Achieva 3T-TX, Philips, the Netherlands). Pulsed ASL 
was performed using EPISTAR strategy for tagging and 
control images with 150 mm thick slab of  tagging pulse 
30 mm far from the imaging region. The plane resolution 
was 3.5 mm × 3.5 mm. Multi-Slice (10 slices) multiphase 
(11 phases) acquisition was performed with a phase in-
terval of  350 ms. No rest slabs or fat suppression pulses 
were applied during acquisition. Thirty repetitions were 
acquired in order to increase the signal to noise ratio. 
ASL data were processed using homemade analysis soft-
ware written in Interactive Data Language 6.3 (Research 
System, Inc.). This analysis program fit the multi-phase 
data of  every pixel to the Günther model[25] for a lock-
looker ASL acquisition, and estimation of  blood flow 
was performed with equation [A2] from reference[25]. The 
analysis program calculated automatically the M0 image 
from ASL data. After image analysis CBF maps are gen-
erated.
Statistical analysis
Values are given as mean ± SEM. Results were analysed 
by one-way ANOVA followed by post-hoc Bonferroni’s 
multiple comparison test. Differences between groups 
were analyzed by Games-Howell test for multiple com-
parisons in the parameters with non-homogeneous vari-
ances. Adjusted P values are shown. Variables that were 
not previously age-adjusted (bimanual coordination and 
visuo-motor coordination) were analysed using univari-
ate analysis of  covariance (ANCOVA) with age included 
as covariate, followed by post-hoc Bonferroni. Bivariate 
correlations among variables were evaluated using the 
Pearson correlation test. The diagnostic performance for 
MHE was assessed using a logistic regression analysis, 
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Figure 1  Blood flow in the different brain regions studied. A: Blood flow in frontal lobe, parietal lobe, occipital lobe, vermis, cerebellar hemisphere and thalamus in 
controls and cirrhotic patients without and with minimal hepatic encephalopathy (MHE); B: Blood flow in cerebellar hemisphere and vermis including the patients (n = 7) 
showing Psychometric Hepatic Encephalopathy Score (PHES) = -3, considered as borderline. Data are expressed as mL of blood per minute per 100 g of brain tissue 
(mean ± SEM) of 14 controls, 24 patients without and 16 with MHE. aP < 0.05; bP < 0.01 vs control, Values significantly different between patients with and without 
MHE are indicated by cP < 0.05.
Felipo V et al . Cerebellar blood flow and minimal HE
11820 September 7, 2014|Volume 20|Issue 33|WJG|www.wjgnet.com
Table 2  Biochemical parameters in blood (mean ± SE)
Parameter Controls Patients without MHE Patients with mHE Patients with MHE P values
(n  = 14) (n  = 24) P  vs  control (n  = 16) P  vs  control P  vs  without MHE
cGMP in plasma (pmol/mL) 0.64 ± 0.1   6.1 ± 0.6   8.7 ± 1.1
    P < 0.0001 P < 0.0001  < 0.05  < 0.0001
Nitrates + Nitrites (μmol/L) 18 ± 1 38 ± 4 44 ± 9
  P = 0.004 P = 0.004 NS    0.001
3-Nitro-tyrosine (nmol/L)   3.5 ± 1.2 10 ± 1 43 ± 6     < 0.0001  < 0.0001
P < 0.0001
IL-6 (pg/mL)   0.7 ± 0.2   2.3 ± 0.3   4.4 ± 0.5      0.001  < 0.0001
P < 0.05 P < 0.0001
IL-18 (pg/mL) 103 ± 13  < 0.05  < 0.0001
268 ± 39 404 ± 44
P = 0.02 P < 0.0001
Ammonia (μmol/L) 39 ± 4   84 ± 14 103 ± 33 NS   0.005
P = 0.04 P = 0.006
One-way analysis of variance (ANOVA) followed by post-hoc Bonferroni’s multiple comparisons test were performed. Adjusted P values are shown. NS: 
Not significant.
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Figure 2  Performance in the Stroop, bimanual and visuo-motor coordination tests. A: Bimanual coordination test; B: Visuo-motor coordination test; C: Stroop 
congruent task; D: Stroop neutral task; E: Stroop incongruent task. Values are the mean ± SEM of 14 controls, 24 patients without and 16 with MHE. aP < 0.05; bP < 0.01 
vs control, Values significantly different between patients with and without MHE are indicated by cP < 0.05; dP < 0.01.
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lours, which was lower than for controls (P < 0.0001) and 
patients without MHE (P = 0.003) (Figure 2D, Table 3). 
In the incongruent task, controls named 42 ± 2 colours. 
Patients without MHE 36 ± 2 colours and patients with 
MHE 28 ± 2 colours, which was lower than for controls 
(P = 0.001) and patients without MHE (P = 0.03) (Figure 
2E, Table 3). Performance in the 5 individual tests of  the 
PHES battery is shown in Table 3.
Correlation analysis between performance in each 
psychometric test and BF in each brain area
BF in cerebellar hemisphere and vermis correlated with 
performance in most tests of  PHES (NCT-A, NCT-B 
and line tracing test) and in the congruent task of  Stroop 
test. BF in frontal lobe correlated with NCT-A (Table 4). 
Performance in bimanual and visuomotor coordination 
tests correlated only with BF in cerebellar hemisphere. 
BF in occipital lobe correlates with global performance 
in the PHES battery and with CFF but not with any indi-
vidual psychometric tests (Table 4). Global performance 
in the PHES correlated with BF in frontal lobe (P = 0.007, 
r = -0.36), occipital lobe (P = 0.031, r = 0.309), cerebellar 
hemisphere (P = 0.01, r = -0.348), and especially in ver-
mis (P < 0.001, r = -0.504).
Correlation analysis between BF in each area and 
biochemical parameters 
BF in cerebellar hemisphere correlates with plasma 
cGMP and NO metabolites (Table 4). BF in vermis 
cerebellar also correlates with NO metabolites and with 
3-nitrotyrosine. IL-18 in plasma correlates with BF in 
thalamus and occipital lobe (Table 4).
Blood flow in cerebellar vermis is predictive for MHE
To assess whether altered BF may be useful to predict 
MHE we performed logistic regression analyses. Univari-
ate logistic regression using the presence of  MHE as the 
dependent variable and blood flow in vermis as indepen-
dent variable shows that BF significantly predicts MHE, 
with an OR of  1.042 (95%CI: 1.006-1.078, P = 0.021). 
ROC curve analysis were performed to determine the 
cut-off, the area under the curve (AUC), and specific-
ity and sensitivity for MHE detection. The ROC curve 
has an AUC of  0.714 (95%CI: 0.54-0.88, P = 0.027) for 
BF in vermis. At the cut-off  of  46 mL/min per 100 g, 
the specificity was 57% and the sensitivity was 69%. Al-
though these values are not excellent for diagnosis, the 
data show that BF in cerebellum is altered in patients 
with MHE and also in some patients without MHE who 
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Table 3  Psychometric tests and attention and coordination tasks in the different groups of cirrhotic patients and in controls (mean 
± SD)
Test Sub-test Controls Patients without MHE Patients with MHE Patients with MHE P values
(n  = 14) (n  = 24) (n  = 16) P  vs  without MHE
P vs  Control P  vs  control
CFF   43.2 ± 0.7 40.5 ± 0.7 36 ± 1 P = 0.001  < 0.001
P < 0.001
PHES Global score   -0.13 ± 0.25 -1.23 ± 0.30 -6.31 ± 0.72
P < 0.001 P < 0.001  < 0.001
Symbol digit test   -0.07 ± 0.12 -0.11 ± 0.08 -0.87 ± 0.12
P < 0.001 P < 0.001  < 0.001
NCT-A   -0.07 ± 0.15 -0.04 ± 0.07 -1.19 ± 0.28
P < 0.001 P < 0.001  < 0.001
NCT-B   -0.07 ± 0.18 -0.27 ± 0.14 -2.07 ± 0.30
P < 0.001 P < 0.001  < 0.001
Serial dotting test     0.00 ± 0.00 -0.57 ± 0.17 -1.19 ± 0.29 NS
P = 0.001     0.002
Line tracing test    -0.07 ± 0.07 -0.15 ± 0.07 -1.25 ± 0.33 P < 0.001 
P < 0.001   < 0.001
Stroop Congruent task 102 ± 5 90 ± 2 76 ± 4
P = 0.03 P < 0.0001 P = 0.009   < 0.0001
Neutral Task   75 ± 3 67 ± 2 54 ± 3
P < 0.0001 P = 0.003   < 0.0001
Incongruent Task   42 ± 2 36 ± 2 28 ± 2 P = 0.030     0.001
P = 0.001
Bimanual coordination     1.73 ± 0.05   2.16 ± 0.05   2.83 ± 0.15
P = 0.05 P < 0.0001 P < 0.0001   < 0.0001
Visuo-motor coordination     2.15 ± 0.08   2.61 ± 0.08   3.89 ± 0.28   < 0.0001
P < 0.0001 P < 0.0001
Statistical analysis: One-way analysis of variance (ANOVA) followed by post-hoc Bonferroni’s multiple comparisons test , except for Bimanual and Visuo-
motor coordination tests, in which univariate analysis of covariance (ANCOVA) was performed, with age included as covariate, followed by post-hoc Bon-
ferroni. Adjusted P values are shown. Stroop test: Congruent task: number of words read in 45 s; Neutral task: Number of colours read in 45 s; Incongruent 
task: Number of items completed in 45 s. Bimanual and Visuo-motor coordination tests: Score in minutes. CFF: Critical Flicker Frequency; PHES: Psycho-
metric Hepatic Encephalopathy Score; NCT-A, NCT-B: Number Connection Test A and B: respectively; NS: Not significant. 
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also show impaired bimanual coordination. This supports 
that altered BF in cerebellum detects some motor defi-
cits earlier that the PHES battery. To get further insight 
on this matter, we sub-classified the patients showing a 
PHES of  -3 (who are usually classified as without MHE) 
as “borderline” patients. There were 7 patients with 
PHES-3. BF in vermis was 60 ± 12 mL/min per 100 g, 
which was nearly significantly different (P = 0.055) from 
controls (Figure 1B). BF in cerebellar hemisphere of  
these “borderline patients” was 37 ± 6 mL/min per 100 g 
which was significantly different (P < 0.01) from controls 
and not different from patients with MHE (Figure 1B). 
This supports that altered BF in cerebellum detects some 
motor deficits earlier than the PHES battery in its present 
form.
DISCUSSION
The results reported show that CBF is increased selec-
tively in the cerebellar vermis and reduced in the occipital 
lobe in patients with MHE compared with patients with-
out MHE. CBF was increased in cerebellar hemispheres 
in cirrhotic patients irrespective of  the presence of  MHE 
as defined according to PHES. This suggests that (1) 
cerebellar hemisphere is the most sensitive region in cir-
rhotic patients; and (2) non invasive determination of  BF 
in cerebellum using ASL would be useful for early detec-
tion of  MHE even before it is detectable with PHES.
Treatment of  HE is associated with lower hospitaliza-
tion frequency and duration, better clinical status, and 
fewer adverse events[26]. We show that non invasive BF 
determination in cerebellum by ASL would allow early 
detection and treatment of  MHE. This would reduce 
societal costs by reducing the number of  motor vehicle 
accidents[27], improve quality of  life and prevent progres-
sion to overt HE.
The data reported show that some motor alterations 
may appear before MHE is detectable using the PHES 
battery. This agrees with previous reports suggesting that 
impairment of  some motor coordination functions are 
early markers for cerebral dysfunction in some patients 
with MHE even prior to neuropsychometric alterations 
becoming detectable[4]. These motor functions are mainly 
modulated in cerebellum, supporting that cerebellar al-
terations would contribute to these early alterations. 
In addition to increased BF in cerebellar hemisphere, 
patients with MHE also show increased BF in cerebellar 
vermis and reduced BF in occipital lobe. Changes in BF in 
specific cortical areas are sensitive early markers of  progres-
sion of  mild cognitive impairment in Alzheimer’s disease[28]. 
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Table 4  Correlations between tests and biochemical parameters and blood flow in the brain areas
Studied parameter/test Sub-test Frontal lobe Parietal lobe Occipital Vermis Cerebellar hemisphere Thalamus
CFF NS NS r = 0.353 r = -0.326 NS NS
P = 0.017 P = 0.025
PHES Global score r = -0.36 NS r = 0.309 r = -0.504 r = -0.348 NS
P = 0.007 P = 0.031 P < 0.001 P = 0.01
Symbol digit test NS NS NS NS NS NS
NCT-A r = -0.469 NS NS r = -0.530 r = -0.320 NS
P < 0.001 P < 0.001 P = 0.018
NCT-B NS NS NS r = -0.531 r = -0.307 NS
P < 0.001 P = 0.027
Serial dotting test NS NS NS NS NS NS
Line tracing test NS NS NS r = -0.330 r = -0.364 NS
P = 0.018 P = 0.007
STROOP Congruent task NS NS NS r = -0.320 r = -0.354 NS
P = 0.027 P = 0.012
Neutral task NS NS NS NS NS NS
Incongruent task NS NS NS NS NS
NS
Bimanual coordination NS NS NS NS r = 0.362 NS
P = 0.011
Visuo-motor coordination NS NS NS NS r = 0.335 NS
P = 0.017
cGMP in plasma (pmoles/mL) NS NS NS NS r = 0.301 NS
P = 0.034
Nitrates + Nitrites (mmol/L) NS NS NS r = 0.339 r = 0.362 NS
P = 0.043 P = 0.023
3-Nitro-tyrosine (nmol/L) NS NS NS r = 0.358 NS NS
P = 0.011
IL-6 (pg/mL) NS NS NS NS NS NS
IL-18 (pg/mL) NS NS r = -0.353 NS NS r = -0.405
P = 0.041 P = 0.032
Ammonia (mmol/L) NS NS NS NS NS NS
PHES: Psychometric Hepatic Encephalopathy Score; NCT-A, NCT-B: Number Connection Test A and B, respectively; CFF: Critical flicker frequency; NS: 
No significant correlation.
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Changes in regional BF could also serve as markers of  
the presence and progression of  MHE. Altered BF may 
contribute to neurological impairment and to impair per-
formance in the PHES and in bimanual and visuo-motor 
coordination and/or in attention tests. BF in cerebellar 
hemisphere correlates with performance in most tests, 
suggesting that increased BF in cerebellar hemisphere 
may be an early relevant contributor to neurological im-
pairment in MHE.
BF in cerebellar hemisphere is also increased in cir-
rhotic patients without MHE, who also show impaired 
bimanual coordination and performance in the congru-
ent task in the Stroop test. This suggests that increased 
BF in cerebellar hemisphere is an early event which may 
contribute to neurological deterioration and reduced per-
formance in bimanual coordination and the congruent 
Stroop task and predisposing to impair visuomotor co-
ordination, executive functioning (NCT-B) and cognitive 
processing speed (NCT-A). 
BF in cerebellar hemisphere and vermis correlate with 
performance in NCT-A and NCT-B (also known as trail 
making test). NCT-B examines executive functioning and 
NCT-A cognitive processing speed[29]. Cerebellar altera-
tions result in impaired executive function and perfor-
mance in NCT test in schizophrenia[30,31], Parkinsonism[32] 
or Cerebellar Cognitive Affective Syndrome[33]. Altered 
BF in cerebellum may contribute to impair executive 
functioning and performance in NCT tests in MHE. 
Bimanual coordination correlates with BF in cerebel-
lar hemisphere but not in other areas. This agrees with 
functional magnetic resonance imaging studies showing 
that cerebellum is a critical site for the control of  biman-
ual coordination[34] and that intercerebellar coupling is key 
for execution of  simultaneous bimanual movements[35]. 
Moreover, both bimanual coordination and BF in cer-
ebellar hemisphere are impaired in patients without MHE 
according to PHES, supporting the idea that altered BF 
in cerebellar hemisphere would contribute to impair bi-
manual coordination. 
The data reported show that patients which are clas-
sified as “without MHE” according to the PHES battery 
have significantly reduced bimanual coordination. We 
have previously shown that patients who do not show 
MHE as detected using the PHES already have some 
psychomotor slowing and impaired bimanual coordina-
tion, indicating that some mild neurological alterations 
are not detected with the PHES but can be detected by 
more sensitive procedures[5]. Butz et al[4] also showed that 
ataxia, tremor, and slowing of  finger movements are early 
markers for cerebral dysfunction in at least a subgroup of  
cirrhotic patients even prior to alterations in performance 
in the PHES become detectable. These data suggest that, 
although the PHES battery is currently the gold standard 
for detection of  the presence of  MHE, and it has been 
very useful to unify the assessment of  neurological al-
terations in cirrhotic patients, is not sensitive enough to 
detect some mild alterations in motor coordination and 
mental processing speed.
Alterations in both bimanual coordination and BF in 
cerebellum are early events, occurring before altered per-
formance in the PHES, this suggests that bimanual coor-
dination tests should be also performed for early MHE 
detection and that non invasive determination of  BF in 
cerebellum using ASL would detect MHE earlier than the 
currently used PHES battery.
Visuo-motor coordination also correlates with BF in 
cerebellar hemisphere but not in other areas. This could 
be expected, as cerebellum is crucial in visuomotor co-
ordination[36]. This further supports that many functions 
modulated by cerebellum are affected in patients with 
MHE and that cerebellum is more susceptible than other 
areas in cirrhotic patients.
Magnetic resonance studies show that cerebellum is 
involved in the Stroop task[37]. Nabeyama et al[37] showed 
that in patients with obsessive-compulsive disorder re-
duced performance in the Stroop test is associated with 
reduced cerebellum activation. Moreover, patients with 
Cerebellar Cognitive Affective Syndrome show reduced 
performance in the Stroop test[33]. This suggests that al-
tered BF in cerebellum could also contribute to impair 
performance in the Stroop test in patients with MHE.
To shed some initial insight on possible mechanisms 
involved in altered CBF in each area in MHE we also 
assessed the correlations between CBF and some bio-
chemical parameters in blood. Ammonia or IL-6 levels 
do not correlate with CBF in any area, suggesting that 
hyperammonemia and IL-6 related inflammation are not 
main direct contributors to alterations in CBF. Serum 
IL-18 correlates with CBF in occipital lobe and thalamus, 
but not in cerebellum. This suggests that some inflamma-
tory factors would contribute to alter CBF in these areas 
but not in cerebellum.
CBF in cerebellar hemisphere correlates with NO me-
tabolites and cGMP, suggesting an association between 
alterations in the NO-cGMP system and in BF in cer-
ebellum but not in thalamus or cortex. This agrees with 
the role of  NO in CBF modulation. Neuronal NO plays 
an essential role in coupling neuronal activity with CBF 
in cerebellum but not in cortex[38,39]. NO modulates BF 
in cerebellum via stimulation of  soluble guanylyl cyclase 
and cGMP formation[38-40]. This suggests that altered 
NO-cGMP pathway could contribute to increase BF in 
cerebellum in patients with MHE and even in cirrhotic 
patients without MHE. 
The NO-cGMP pathway is strongly altered in 
blood[25,41-43] and cerebellum[44] of  cirrhotic patients with 
MHE or died in HE. Moreover, altered activation of  gua-
nylate cyclase by NO in lymphocytes correlates with the 
MHE grade in cirrhotic patients. It has been suggested 
that altered NO-cGMP pathway contributes to cognitive 
impairment in MHE[42]. The contribution of  altered NO-
cGMP pathway in cerebellum to cognitive impairment 
has been clearly established in animal models of  MHE. 
Rats with MHE have reduced ability to learn a Y maze 
task, which is a consequence of  impaired function of  the 
glutamate-NO-cGMP pathway in cerebellum. Learning 
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ability is restored by treatments that restore the pathway 
and cGMP levels[12-14,45].
These data suggest the idea that, in patients with 
MHE, altered NO-cGMP pathway is associated with al-
tered CBF in cerebellum which, in turn, may contribute 
to induce MHE, impairing bimanual and visuo-motor 
coordination, executive functioning, cognitive process-
ing speed and performance in the PHES. If  this were 
the case, treatments normalizing the NO-cGMP pathway 
could improve CBF in cerebellum and cognitive function 
in cirrhotic patients with MHE. 
In summary, the data support that: (1) CBF is more 
sensitive in cerebellum than in other areas of  cirrhotic 
patients; (2) altered CBF in cerebellum is an early event 
contributing to initiate neurological deterioration, impair-
ing bimanual coordination and the congruent Stroop task 
and predisposing to impair visuomotor coordination, 
executive functioning and cognitive processing speed; 
(3) altered NO-cGMP pathway would contribute to alter 
CBF in cerebellum; and (4) non invasive determination 
of  CBF in cerebellum using ASL may detect MHE earlier 
than the currently used PHES battery.
COMMENTS
Background
Patients with minimal hepatic encephalopathy (MHE) show neurological impair-
ment in specific tasks to which selective regional alterations in blood flow (BF) 
could contribute. Invasive positron emission tomography and single photon 
emission computed tomography techniques have shown altered cerebral blood 
flow patterns in cirrhotic patients, but there is a large variability between the 
results published. The possible contribution of alterations in BF in specific brain 
areas to neurological alterations in patients with MHE remains unclear. Previ-
ous reports suggest that impairment of some motor coordination functions are 
early markers for cerebral dysfunction in some patients with MHE even prior to 
neuropsychometric alterations becoming detectable. These motor functions are 
mainly modulated in cerebellum, supporting that cerebellar alterations would 
contribute to these early alterations. 
Research frontiers
Arterial spin labeling (ASL) is a non-invasive magnetic resonance technique 
that measures quantitatively cerebral perfusion by magnetically labeling protons 
in arterial blood water. This study assess whether non invasive BF measure-
ment by ASL in several brain regions detects MHE and/or specific neurological 
alterations. 
Innovations and breakthroughs
The authors analyzed BF by ASL in different brain areas of controls and cirrhot-
ic patients without and with MHE. The authors found that BF is more affected in 
cerebellum than in other areas of cirrhotic patients and that BF determination in 
cerebellum using ASL may detect MHE earlier than the Psychometric Hepatic 
Encephalopathy Score (PHES) battery. Altered NO-cGMP pathway seems to be 
associated to altered BF in cerebellum. 
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tively cerebral perfusion by magnetically labeling protons in arterial blood water. 
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the “gold standard” in the diagnosis of MHE. NO-cGMP pathway is an intracel-
lular signaling pathway involved in important brain functions.
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encephalopathy as well as other psychometric tests in patients with cirrhosis. 
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